UK
-
The UK supermarket landlord wants to raise £100m to fund growth towards a goal of 10% market share, according to one of its co-founders -
UK biotech company's 43% pop dispels "the idea you cannot IPO a life sciences company in the UK," said a source
-
Pricing 'fair' on £1bn raise but no pop on volatile day
-
The recap is intended to position easyJet for growth opportunities following the loosening of travel restrictions across Europe over the summer
-
Hiring bolsters Northern European DCM team
-
UK insurer's 'defensive' investment status made it popular with investors
-
The UK biotech company has chosen to list on its home market rather than go to the Nasdaq in New York, the traditional listing venue for companies in the industry
-
Private equity assets tempt investors in volatile markets
-
-
The French bank can’t afford to give up on to its UK equity capital markets business as it plots a path to a top three spot in European ECM over the next five years, writes David Rothnie
-
Oxford Nanopore has decided to list on its home exchange rather than the Nasdaq in New York
-
UK brokerage has decided to float again after a 21 year absence
